Ligand validation:5CGV

0N8: (2Z)-4-[1-benzyl-4-(4-chlorobenzyl)piperidin-4-yl]-2-hydroxy-4-oxobut-2-enoic acid

0N8 is a Ligand Of Interest in 5CGV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CGV_0N8_A_303	66%	7%	0.115	0.918	1.44	3.43	3	17	0	0	100%	1
5D9J_0N8_A_203	53%	4%	0.113	0.916	2.57	3.08	12	12	0	0	76%	0.7586
5D8U_0N8_A_203	52%	6%	0.162	0.962	2.45	2.61	8	10	0	0	76%	0.7586
4E5H_0N8_D_305	3%	11%	0.429	0.787	1.24	2.95	4	12	6	0	100%	1
5T2T_0N8_A_203	56%	6%	0.139	0.912	2.36	2.68	9	8	5	0	100%	0.8445
5FDG_0N8_A_204	36%	0%	0.188	0.879	3.51	5.82	14	15	2	0	100%	1
7OA4_0N8_BBB_201	33%	30%	0.271	0.954	1.1	1.68	2	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.